CLDN18 and gastric cancer: Meanwhile, we observed that intravenously injecting mice with the same number of CLDN18.2-GFP gastric cancer cells in combination with CAFs significantly increased the incidence of pulmonary embolism and led to a higher mortality rate compared to the control group (Fig. 4e).